Semax vs Selank — Cognition Research Compared
Semax and Selank are both Russian-origin synthetic peptides studied in the neurotrophic-pathway and CNS-signalling research literature. Researchers investigate them for different — and complementary — angles on cognitive and anxiolytic pathway work.
Semax is a synthetic analogue of ACTH(4-10) studied for BDNF-pathway research. Selank is a tetrapeptide derived from tuftsin studied for anxiolytic-pathway research. They are often included together in the same neurotrophic-research literature because they engage distinct but complementary signalling axes. Peptify stocks both, plus a pre-blended 20mg Cognition vial.
Both peptides in this comparison are available with full Janoshik Analytical Certificate of Analysis from Peptify UK. The page is provided for research-context and procurement-decision purposes only. All Peptify products are supplied strictly for in-vitro research use. Not for human consumption.
Browse both compounds:
- Peptify research library — full peptide-by-peptide research hubs
- How Janoshik Analytical COA testing works
- Published Certificates of Analysis
For research use only. Not for human consumption. PEPTIFY LIMITED #17021295.